MARKET

KMDA

KMDA

Kamada Ltd
NASDAQ
8.21
+0.19
+2.37%
After Hours: 8.25 +0.04 +0.49% 19:39 02/06 EST
OPEN
8.03
PREV CLOSE
8.02
HIGH
8.23
LOW
8.02
VOLUME
30.51K
TURNOVER
--
52 WEEK HIGH
8.90
52 WEEK LOW
5.54
MARKET CAP
473.56M
P/E (TTM)
23.34
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KMDA last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at KMDA last week (0119-0123)?
Weekly Report · 01/26 09:38
Weekly Report: what happened at KMDA last week (0112-0116)?
Weekly Report · 01/19 09:41
Weekly Report: what happened at KMDA last week (0105-0109)?
Weekly Report · 01/12 09:40
Hubspot Stock Set to Rise, Says Analyst. Plus, McGraw Hill, UHS, and More Stocks.
Barron‘s · 01/09 22:07
Kamada 2025/2026 Outlook: Evaluating Revenue Growth And Product Drivers
Seeking Alpha · 01/08 14:34
Kamada: Core Business Resilience and Strategic Expansion Support Buy Rating and $13 Price Target Despite Pipeline Setbacks
TipRanks · 01/08 11:46
Kamada forecasts double-digit profitable growth in 2026
Seeking Alpha · 01/07 16:49
More
About KMDA
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Webull offers Kamada Ltd stock information, including NASDAQ: KMDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KMDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KMDA stock methods without spending real money on the virtual paper trading platform.